Biogen (BIIB) Change in Intangibles (2011 - 2025)

Biogen (BIIB) recorded quarterly Change in Intangibles of $16.3 million in Q4 2025, up 207.55% quarter-over-quarter from $5.3 million in Q3 2025, and up 8.67% on a YoY basis from $15.0 million in Q4 2024.

Biogen (BIIB) Change in Intangibles (2011 - 2025) Analysis & Trends

Biogen's Change in Intangibles history runs 14 years deep, the most recent figure standing at $16.3 million for Q4 2025.

  • In Q4 2025, Change in Intangibles rose 8.67% year-over-year to $16.3 million; the TTM figure through Mar 2026 stood at $21.6 million (down 83.27% YoY), while the FY2025 annual figure was $31.6 million, down 84.67% from the prior year.
  • Change in Intangibles was $16.3 million for Q4 2025 at Biogen, up from $5.3 million in the prior quarter.
  • In the past five years, Change in Intangibles ranged from a high of $95.0 million in Q3 2024 to a low of $1.0 million in Q4 2022.
  • Historically, Change in Intangibles has averaged $20.1 million across 5 years, with a median of $11.7 million in 2023.
  • The sharpest annual moves came in 2024 and 2025: Change in Intangibles surged 1400.0% in 2024, then tumbled 94.42% in 2025.
  • A 5-year view of Change in Intangibles shows it stood at $16.9 million in 2021, then sank by 94.08% to $1.0 million in 2022, then soared by 1240.0% to $13.4 million in 2023, then grew by 11.94% to $15.0 million in 2024, then advanced by 8.67% to $16.3 million in 2025.
  • The last three Change in Intangibles figures came in at $16.3 million (Q4 2025), $5.3 million (Q3 2025), and $10.0 million (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Intangibless (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn -299.30 Mn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn -
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn -
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn -
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn -
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn -
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn -
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn -
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn -
10 Biogen 28.75 Bn 24.47 Bn 1.82 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2025 16.30 Mn
Dec 31, 2025 16.30 Mn
Sep 30, 2025 5.30 Mn
Sep 30, 2025 5.30 Mn
Mar 31, 2025 10.00 Mn
Mar 31, 2025 10.00 Mn
Dec 31, 2024 15.00 Mn
Dec 31, 2024 15.00 Mn
Sep 30, 2024 95.00 Mn
Sep 30, 2024 95.00 Mn
Jun 30, 2024 9.10 Mn
Jun 30, 2024 9.10 Mn
Mar 31, 2024 75.00 Mn
Mar 31, 2024 75.00 Mn
Sep 30, 2023 13.40 Mn
Sep 30, 2023 13.40 Mn
Jun 30, 2023 16.00 Mn
Jun 30, 2023 16.00 Mn
Mar 31, 2023 5.00 Mn
Mar 31, 2023 5.00 Mn